Ovarian cancer survival by residual disease following cytoreductive surgery: a nationwide study in Norway
Achieving NMRD resulted in the best survival outcomes. Among patients with RD, we observed no significant difference in survival by RD diameter.
Authors
- Torbjørn Paulsen (ORCID: https://orcid.org/0000-0001-9505-8405)
- Renée T. Fortner (ORCID: https://orcid.org/0000-0002-1426-8505)
- Hilde Langseth (ORCID: https://orcid.org/0000-0002-9446-4855)
- Cassia B. Trewin-Nybråten (ORCID: https://orcid.org/0000-0001-8236-9423)
- Sigrid Leithe
Institutions
- Oslo University Hospital (NO)
- Norwegian Institute of Public Health (NO)
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- Cancer Registry of Norway (NO)
- Imperial College London (GB)
Publication Details
- Journal
- British Journal of Cancer
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1038/s41416-025-03018-0
- Citations
- 2
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.40